Sign in
4

Changes in Ownership

Viking Therapeutics, Inc. Filed Acc 0001209191-23-024228

President & CEO sold 79,336 shares at $18.45 ($1,463,749)

  • President & CEO acquired 54,336 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lian Brian · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-13 Exercise or conversion : show line 1 in the form +54,336 $1.88 $102,152 2,387,299 D
2023-04-13 Sale : show line 2 in the form −79,336 $18.45 $1,463,749 2,307,963 D
Open-market sales · 79,336 sh · avg $18.45 · $1,463,749

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-13 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −54,336 0 D
Loading xslF345X04/doc4.xml…